147 Results for "

interface

" in MedChemExpress (MCE) Product Catalog:
Products (147)

147 Results for "interface" in MCE Product Catalog:

Cat. No.: HY-117401
CAS No.: 107827-77-0
Purity:  99.32%
5-Dodecanoylaminofluorescein is an amphipathic (amphoteric) fluorescent probe (Ex/Em = 485 nm/515-535 nm), which consists of a hydrophilic fluorescein core and a hydrophobic dodecanoyl group (C12 fatty acid chain) linked by an amide bond. 5-Dodecanoylaminofluorescein is mainly used as an interface-localized radical trapping/indicator probe. Dodecanoylaminofluorescein can be used for the determination of the antioxidant properties of emulsions, or can serve as a lipophilic drug model for the study of passive skin penetration when encapsulated in tyrosine-derived nanospheres .
loading...
    loading...
Cat. No.: HY-W041994
CAS No.: 80307-12-6
GMBS is a heterobifunctional crosslinker targeting primary amines and sulfhydryl groups. GMBS can be used for chemical crosslinking of proteins and crosslinking mass spectrometry (CXMS) to study protein folding and map interfaces between interacting proteins .
loading...
    loading...
Cat. No.: HY-153937
CAS No.: 2760612-77-7
Purity:  99.67%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

Skp2 inhibitor 2 is a Skp2-Cks1 protein-protein interaction inhibitor with a human IC50 of 0.57 μM. Skp2 inhibitor 2 binds to Skp2 at the interaction interface to block Skp2-Cks1 complex formation. Skp2 inhibitor 2 can be used for the research of gastric cancer, non-small cell lung cancer, breast cancer, prostate cancer .
loading...
    loading...
Cat. No.: HY-147255
CAS No.: 2137847-19-7
Purity:  98.40%
Synonyms: ZM-H1505R
Target:  

HBV

Research Areas:  

Infection

Canocapavir (ZM-H1505R) is an orally active HBV core protein-targeting antiviral agent. Canocapavir binds to the hydrophobic pocket at the dimer-dimer interface of HBV core protein (HBc), stimulating intracellular accumulation of nonfunctional HBV capsids, disrupting viral replication. Canocapavir interferes with the interaction between HBc and HBV large surface protein, resulting in diminished
production of empty virionsis. Canocapavir can be used for the research of hepatitis B virus (HBV) infection .
loading...
    loading...
Cat. No.: HY-P11017
CAS No.: 1152066-26-6
Target:  

p38 MAPK Cadherin

Research Areas:  

Inflammation/Immunology

LNSMGQD is a cyclic peptide fragment derived from desmoglein 1 (amino acids 81-86), which mimics trans-interactions and acts as part of the tandem peptide binding interface of desmoglein 2. LNSMGQD not only binds to desmoglein 1 and 3, but also effectively inhibits their homophilic trans-interactions, while reducing the probability of homophilic or heterophilic binding between desmoglein 2 and Dsc2, N-cadherin and E-cadherin. LNSMGQD is applicable to the research on disease mechanisms such as Crohn's disease and pemphigus vulgaris .
loading...
    loading...
Cat. No.: HY-W133920
CAS No.: 25322-69-4
Synonyms: PPG 2000
Polypropylene glycol 2000 (PPG 2000) is a polyether produced by ring-opening polymerization of propylene oxide. Polypropylene glycol 2000 has low toxicity, and acts as a dispersant for leather finishing materials, as well as a surfactant and wetting agent for pharmaceutical preparations .
loading...
    loading...
Cat. No.: HY-153074
CAS No.: 1628478-15-8
Purity:  98.25%
Research Areas:  

Infection

ISR-IN-1 is an integrated stress response (ISR) inhibitor targeting eIF2B. ISR-IN-1 enhances eIF2B guanine nucleotide exchange factor activity, stabilizes eIF2B heteropentamer dimers via symmetrical protein-protein interface binding, and releases global protein synthesis inhibition from phosphorylated eIF2α α. ISR-IN-1 can be used for the research of prion disease .
loading...
    loading...
Cat. No.: HY-122627
CAS No.: 678158-55-9
Purity:  99.14%
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

CLZ-8 (Compound 8) is an orally active Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. CLZ-8 exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells .
loading...
    loading...
Cat. No.: HY-124066
CAS No.: 1182129-77-6
Purity:  98.72%
Target:  

TAM Receptor

Research Areas:  

Cancer

RU-302 is a pan TAM inhibitor that blocks the interface between the TAM Ig1 ectodomain and the Gas6 Lg domain. RU-302 effectively blocks Gas6-inducible Axl receptor activation with a low micromolar IC50in cell assays, and suppresses lung cancer tumor growth .
loading...
    loading...
Cat. No.: HY-P1805
CAS No.: 104041-80-7
Target:  

Calmodulin

Research Areas:  

Neurological Disease

Calmodulin Binding Peptide 1 is a high-affinity (pM) CaM-binding peptide derived from smooth muscle myosin light chain kinase (MLCK peptide). The interface of the complex formed by Calmodulin Binding Peptide 1 and Ca 2+-CaM can be specifically bound by small-molecule inhibitors, serving as a key target for selective regulation of smooth muscle contraction and development of anti-CaM drugs .
loading...
    loading...
Cat. No.: HY-W284558
CAS No.: 1120-01-0
Sodium hexadecyl sulfate is a long-chain anionic surfactant. Sodium hexadecyl sulfate can act as an interface-regulating substance to form a soft layer on the surface of carbon nanotubes, guide proteins to adsorb in the correct orientation with active sites facing outward through electrostatic interactions, and significantly enhance the activity of immobilized enzymes. Sodium hexadecyl sulfate can replace or supplement SDS (HY-Y0316) in capillary gel electrophoresis (CGE) .
loading...
    loading...
Cat. No.: HY-W014861
CAS No.: 75-58-1
Synonyms: Tetramethyl-ammoniuiodide
Tetramethylammonium iodide (Tetramethyl-ammoniuiodide) is a capillary active agent and weakly capillary active quasi-simple salt. Tetramethylammonium iodide decreases aqueous solution surface tension with increasing concentration and exhibits surface accumulation of constituent ions at liquid-vapor interfaces .
loading...
    loading...
Cat. No.: HY-21170B
CAS No.: 33454-82-9
Synonyms: Triflate lithium; Trifluoromethylsulfonate lithium; Trifluoromethanesulphonic acid lithium
Trifluoromethanesulfonate (Triflate;Trifluoromethylsulfonate) lithium is a stable lithium salt and dopant with four resonance states, which is commonly used as an electrolyte component in polymer light-emitting electrochemical cells and primary lithium batteries. Trifluoromethanesulfonate lithiumalso acts as a catalyst for the preparation of the herbicide Imazapyr. In MEH-PPV-based light-emitting electrochemical cells, Trifluoromethanesulfonate lithium promotes electrochemical p-type doping at the anode interface under applied bias, thereby facilitating the formation of p-i-n junctions, exciton generation, and light emission. Trifluoromethanesulfonate lithiumexhibits strong ion pairing in non-aqueous electrolytes, but its electrochemical stability window is narrower than that of lithium bistrifluoromethylsulfonyl imidee .
loading...
    loading...
Cat. No.: HY-178042
CAS No.: 2756257-56-2
Target:  

Ras Akt ERK

Research Areas:  

Cancer

SS-3091 is a pan-KRas inhibitor active across KRas G12D, KRas G12C, KRas G12V, KRas G12S mutants, with minimal effects on non-KRas-driven cancer cells. SS-3091 binds to the KRas·ARaf interaction interface, destabilizes the complex, and attenuates KRas activity. SS-3091 suppresses phosphorylation of S6K, Akt, and ERK. SS-3091 reduces proliferation and decreases colony formation of cancer cells bearing KRas G12 mutations. SS-3091 can be used for the research of KRas-driven cancers .
loading...
    loading...
Cat. No.: HY-171444
CAS No.: 1493797-28-6
Target:  

γ-secretase Amyloid-β

Research Areas:  

Neurological Disease

GSM III is a γ-Secretase complexe (GSEC) modulator. GSM III significantly regulates amyloid-β (Aβ) length at the extracellular interface between the protease (NCT, PSEN) and the substrate APPC99. GSM III can be used for Alzheimer's disease (AD) research .
loading...
    loading...
Cat. No.: HY-W611371
CAS No.: 61694-81-3
Target:  

TRP Channel iGluR

Research Areas:  

Neurological Disease

FP802 is an orally active potent TwinF interface inhibitor that disrupts and detoxifies the NMDAR/TRPM4 death complex. FP802 exerts powerful neuroprotective effects in the 5xFAD mouse model of Alzheimer’s disease (AD) by preventing cognitive decline, preserving neuronal structural integrity, reducing amyloid-β plaque formation, and mitigating mitochondrial pathology . FP802 stops loss of motor neurons, reduces serum neurofilament light chain (NfL) levels, improves motor performance, and extends life in a mouse model of amyotrophic lateral sclerosis (ALS). FP802 can be used for AD and ALS research .
loading...
    loading...
Cat. No.: HY-N0347
CAS No.: 302-23-8
Target:  

Progesterone Receptor

Research Areas:  

Endocrinology

17α-Hydroxyprogesterone acetate possesses progestational activity. 17α-Hydroxyprogesterone acetate has antiinflammatory effects at the murine maternal-fetal interface .
loading...
    loading...
Cat. No.: HY-121068
CAS No.: 17692-24-9
Research Areas:  

Infection

Bisoxatin is a laxative drug used for constipation. Bisoxatin binds substantially at the S-protein-ACE2 interface. Bisoxatin has the potential for inhibiting SARS-CoV-2 entry into the host research .
loading...
    loading...
Cat. No.: HY-W099642
CAS No.: 2083-68-3
Synonyms: Trimethyl-n-octylammonium bromide
Trimethyloctylammonium bromide (TOAB) is used as a surfactant and phase transfer catalyst in various chemical reactions. TOAB can be used in the synthesis of nanomaterials due to its ability to selectively transfer ions across interfaces and as a surfactant in the production of emulsions and foams. It is valued for its amphiphilic properties, which allow it to interact with water and oils, stabilizing and dispersing mixtures.
loading...
    loading...
Cat. No.: HY-P10436
CAS No.: 2411851-64-2
Target:  

Raf

Research Areas:  

Cancer

Braftide is an allosteric inhibitor for BRAF kinase by targeting the dimer interface of BRAF kinase and inhibiting the formation of BRAF dimers. Braftide inhibits wild-type BRAF and oncogenic BRAF G469A with IC50 of 364 nM and 172 nM, respectively. Braftide inhibits MAPK signaling pathway, inhibits proliferation of KRAS mutant tumor cells (EC50 is 7.1 and 6.6 μM, for HCT116 and HCT-15), in combination of TAT sequence. Braftide can be used for cancer research .
loading...
    loading...